Excitatory amino acid antagonists: Behavioral and biochemical approaches for the development of new central nervous system therapeutic agents
- 1 January 1989
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 17 (4) , 339-365
- https://doi.org/10.1002/ddr.430170409
Abstract
No abstract availableKeywords
This publication has 109 references indexed in Scilit:
- A comparison of PCP-like compounds for NMDA antagonism in two modelsLife Sciences, 1988
- cGMP synthesis in cultured cerebellar neurons is stimulated by glutamate via a Ca2+-mediated, differentiation-dependent mechanismDevelopmental Brain Research, 1987
- N-methyl-d-aspartate produces discriminative stimuli in ratsLife Sciences, 1987
- 2-amino-7-phosphonoheptanoic acid (AP7) produces discriminative stimuli and anticonflict effects similar to diazepamLife Sciences, 1986
- Phencyclidine-like behavioral effects in pigeons induced by systemic administration of the excitatory amino acid antagonist, 2-amino-5-phosphonovalerateLife Sciences, 1986
- Inhibition of quisqualate-induced seizures by glutamic acid diethyl ester and anti-epileptic drugsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1986
- A reversible type of neuronal injury following ischemia in the gerbil hippocampus.Stroke, 1986
- Muscle relaxant action of excitatory amino acid antagonistsNeuroscience Letters, 1985
- II. Excitotoxic models for neurodegenerative disordersLife Sciences, 1984
- Specific binding of heptanoic acid to rat brain membranes in vitroLife Sciences, 1983